DAPA-HF trial signals the birth of ‘diabetic cardiology’ and more

類似資料

• The EMPEROR-Reduced trial: SGLT2 inhibitors for heart failure get more support
  著者:: Wagdy, Kerolos
  出版事項: (2020)
• NEAT HFpEF: Organic nitrates fail to deliver
  著者:: Wagdy, Kerolos, 等
  出版事項: (2016)
• ASGR1 - a new target for lowering non-HDL cholesterol
  著者:: Hassan, Mohamed, 等
  出版事項: (2016)
• DAPA-HF study: Are the benefits uniform across non-diabetic subgroups
  著者:: Pareek, Anil, 等
  出版事項: (2020)
• Takotsubo cardiomyopathy: A potentially serious trap (Data from the International Takotsubo Cardiomyopathy Registry)
  著者:: Wagdy, Kerolos, 等
  出版事項: (2015)